Cryoport inks new multi-year supply chain solutions agreement with monash ivf

Nashville, tenn. , oct. 12, 2023 /prnewswire/ -- cryoport, inc. (nasdaq: cyrx) ("cryoport" or the "company"), a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine for a new era of life sciences, today announced that the company has signed a new three-year supply chain solutions agreement with monash ivf group limited (asx: mvf), a leading provider of assisted reproductive services, as well as specialist women's imaging and diagnostic services in australia and southeast asia.
CYRX Ratings Summary
CYRX Quant Ranking